The Epidemiology, Pathophysiology, and Novel Treatment of Calcific Arterial Disease

Lucyna Z Price1, Peter L Faries1, James F McKinsey2

  • 1Department of Vascular Surgery, Mount Sinai Hospital, New York, New York.

Insights

Intravascular lithotripsy (IVL) effectively treats calcified arterial lesions, improving outcomes for peripheral arterial disease and vascular access procedures like EVAR and TAVR. This technology allows safer angioplasty with enhanced vessel compliance.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Medical Devices

Background:

  • Endovascular treatments are standard for arterial diseases, but severe calcification hinders procedures.
  • Calcified lesions pose challenges for peripheral arterial disease (PAD) and vascular access for EVAR and TAVR.

Purpose of the Study:

  • Introduce the Peripheral Intravascular Lithotripsy (IVL) System for treating calcific lesions.
  • Demonstrate IVL's utility in preparing access vessels for EVAR/TAVR and treating PAD.
  • Highlight IVL's potential to enhance luminal gain and vessel compliance.

Main Methods:

  • Utilized the Peripheral Intravascular Lithotripsy (IVL) System, applying pulsatile mechanical energy.
  • Performed treatment under fluoroscopic guidance to disrupt calcified lesions.
  • Described successful case applications and potential benefits in challenging cases.

Main Results:

  • IVL enables angioplasty at lower pressures, potentially reducing arterial dissection.
  • The lithotripsy effect improves vessel compliance by addressing calcification.
  • Successful application of IVL in selected cases was observed.

Conclusions:

  • Intravascular lithotripsy is a promising technology for managing complex calcific arterial disease.
  • IVL facilitates endovascular procedures by preparing calcified vessels, improving outcomes for PAD, EVAR, and TAVR.
  • Further investigation into IVL's broad applicability and benefits is warranted.

Related Concept Videos

Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
420
Peptic Ulcer Disease II: Pathophysiology01:28

Peptic Ulcer Disease II: Pathophysiology

Peptic Ulcer Disease (PUD) is characterized by the development of ulcers in the stomach or duodenal mucosa. Its pathophysiology is complex, involving a balance between damaging and protective elements.
Damaging agents such as Helicobacter pylori, gastric acid, pepsin, and nonsteroidal anti-inflammatory drugs (NSAIDs) can weaken the mucosal defense, allowing hydrogen ions to infiltrate back and harm epithelial cells.
2.0K
Gastroesophageal Reflux Disease I: Meaning and Pathophysiology01:29

Gastroesophageal Reflux Disease I: Meaning and Pathophysiology

Gastroesophageal Reflux Disease (GERD) involves the recurrent backflow of the stomach or duodenal contents into the esophagus, leading to troublesome symptoms and potential esophageal mucosal damage. Although GERD is often referred to as a disease, it is more accurately described as a syndrome, as it encompasses a range of symptoms and complications rather than a singular pathological entity, impacting a large number of individuals as the most prevalent upper gastrointestinal problem. Roughly...
1.6K
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of...
1.1K
Alzheimer's Disease: Treatment01:22

Alzheimer's Disease: Treatment

Alzheimer's Disease (AD), a neurodegenerative disorder, is pathologically identified by amyloid plaques and neurofibrillary tangles composed of tau protein. AD pharmacotherapy aims to manage cognitive symptoms, delay disease progression, and treat behavioral symptoms. The treatment is primarily symptomatic and palliative, with no definitive disease-modifying therapy available. Cholinesterase inhibitors, including donepezil (Aricept), rivastigmine (Exelon), and galantamine (Razadyne), are...
914
Pathophysiology of Peptic Ulcer Disease: Injurious Factors01:22

Pathophysiology of Peptic Ulcer Disease: Injurious Factors

Peptic ulcers are sores on the stomach's inner lining and the upper small intestine, which are the result of disruptions in the mucosal layer that houses parietal cells which produce gastric acid, and chief cells which secrete pepsinogen.
In the antrum region, G cells secrete the gastrin hormone that binds to gastrin-cholecystokinin-B (CCK2) receptors on parietal and enterochromaffin-like (ECL) cells in the fundic glands. Simultaneously, the vagus nerve releases acetylcholine, which binds...
1.2K